Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Chao Liang, Jie Li, Cheng Lu, Duoli Xie, Jin Liu, Chuanxin Zhong, Xiaohao Wu, Rongchen Dai, Huarui Zhang, Daogang Guan, Baosheng Guo, Bing He, Fangfei Li, Xiaojuan He, Wandong Zhang, Bao-Ting Zhang, Ge Zhang, Aiping Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a92efca7bad644fb891938c6c0cde185 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
por: Chao Liang, et al.
Publicado: (2019) -
PredCRP: predicting and analysing the regulatory roles of CRP from its binding sites in Escherichia coli
por: Ming-Ju Tsai, et al.
Publicado: (2018) -
CRP-level-associated polymorphism rs1205 within the CRP gene is associated with 2-hour glucose level: The SAPPHIRe study
por: Wayne Huey-Herng Sheu, et al.
Publicado: (2017) -
The secondary messenger ppGpp interferes with cAMP-CRP regulon by promoting CRP acetylation in Escherichia coli.
por: Chunghwan Ro, et al.
Publicado: (2021) -
The secondary messenger ppGpp interferes with cAMP-CRP regulon by promoting CRP acetylation in Escherichia coli
por: Chunghwan Ro, et al.
Publicado: (2021)